Everolimus

Business Offer

United States

Everolimus is a Kinase Inhibitor and mTOR Inhibitor Immunosuppressant. The mechanism of action of everolimus is as a Protein Kinase Inhibitor and Cytochrome P450 3A4 Inhibitor and P-Glycoprotein Inhibitor and Cytochrome P450 2D6 Inhibitor and mTOR Inhibitor. The physiologic effect of everolimus is by means of Decreased Immunologic Activity. For more information, please visit the website: https://www.creative-peptides.com/product/everolimus-item-z10-101-155-34587.html

[RequestAdvantages]

[RequestComments]

743

Cathy Miller